Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,929,481
+$12,635,493 QoQ
Shares Held
954,910
+3369.0% QoQ
Ownership
0.364%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#41
of 626 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. OGN ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
This page
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,929,481 | 954,910 | Shares | Sole | 2026-08-12 | |
| 2025-09-30 | $293,988 | 27,527 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $351,751 | 36,338 | Shares | Sole | 2025-08-13 | |
| 2022-03-31 | $550,147 | 15,750 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $784,087 | 25,750 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $874,673 | 26,675 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,097,711 | 36,276 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||